• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Valtrex (valacyclovir hydrochloride) caplets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2010

 

Summary View

 

WARNINGS and PRECAUTIONS

Central Nervous System Effects
  • Elderly patients are more likely to have central nervous system adverse reactions